ROGER KORNU
- Type
- Physician · Allopathic & Osteopathic Physicians / Internal Medicine / Rheumatology
- Where
- TUSTIN, CA
- NPI
- 1841386349
- Received
- $824,971 in 2,369 records, 2019 to 2025 ($801,914 general, $23,056 research)
- As principal investigator
- $56,992 of research payments to others in 15 records
- Source
- CMS Open Payments search ↗
By year
| Program year | Kind | Records | Amount |
|---|---|---|---|
| 2025 | General payment | 398 | $157,327 |
| 2024 | General payment | 307 | $113,484 |
| 2023 | General payment | 275 | $64,389 |
| 2022 | General payment | 329 | $77,583 |
| 2021 | General payment | 301 | $104,081 |
| 2020 | General payment | 228 | $54,373 |
| 2020 | Research payment | 3 | $3,049 |
| 2019 | General payment | 527 | $230,675 |
| 2019 | Research payment | 1 | $20,007 |
By company
By nature of payment
| Nature | Records | Amount |
|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a v | 225 | $418,506 |
| Consulting Fee | 51 | $129,795 |
| Honoraria | 59 | $115,655 |
| Travel and Lodging | 316 | $84,760 |
| Food and Beverage | 1,704 | $53,082 |
| Research payment | 4 | $23,056 |
| Education | 10 | $114 |
Records
| Date | Company | Amount | Nature | Form | Product | Study | Year |
|---|---|---|---|---|---|---|---|
| 2025-12-30 | ABBVIE INC. | $2,125 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | RINVOQ Biological, IMMUNOLOGY | 2025 | |
| 2025-12-22 | ABBVIE INC. | $2,125 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | SKYRIZI Biological, IMMUNOLOGY | 2025 | |
| 2025-12-22 | Amgen Inc. | $389 | Travel and Lodging | In-kind items and services | KRYSTEXXA Biological, Inflammation/Rare Disease | 2025 | |
| 2025-12-18 | Amgen Inc. | $31 | Food and Beverage | In-kind items and services | ENBREL Biological, Inflammation | 2025 | |
| 2025-12-17 | ABBVIE INC. | $32 | Food and Beverage | In-kind items and services | SKYRIZI Biological, IMMUNOLOGY | 2025 | |
| 2025-12-16 | Amgen Inc. | $28 | Food and Beverage | In-kind items and services | KRYSTEXXA Biological, Inflammation/Rare Disease | 2025 | |
| 2025-12-15 | E.R. Squibb & Sons, L.L.C. | $231 | Travel and Lodging | Cash or cash equivalent | 2025 | ||
| 2025-12-15 | E.R. Squibb & Sons, L.L.C. | $46 | Food and Beverage | Cash or cash equivalent | 2025 | ||
| 2025-12-15 | Radius Health, Inc. | $29 | Food and Beverage | In-kind items and services | Tymlos Drug, Endocrinology | 2025 | |
| 2025-12-12 | Amgen Inc. | $5 | Food and Beverage | In-kind items and services | KRYSTEXXA Biological, Inflammation/Rare Disease | 2025 | |
| 2025-12-11 | UCB, Inc. | $2,500 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Bimzelx Biological, Immunology | 2025 | |
| 2025-12-11 | Novartis Pharmaceuticals Corporation | $13 | Food and Beverage | In-kind items and services | COSENTYX Drug, Dermatology | 2025 | |
| 2025-12-10 | ABBVIE INC. | $124 | Food and Beverage | In-kind items and services | RINVOQ Biological, IMMUNOLOGY | 2025 | |
| 2025-12-10 | ABBVIE INC. | $23 | Food and Beverage | In-kind items and services | SKYRIZI Biological, IMMUNOLOGY | 2025 | |
| 2025-12-10 | Amgen Inc. | $18 | Food and Beverage | In-kind items and services | KRYSTEXXA Biological, Inflammation/Rare Disease | 2025 | |
| 2025-12-09 | GENZYME CORPORATION | $19 | Food and Beverage | In-kind items and services | KEVZARA Biological, Rheumatology | 2025 | |
| 2025-12-08 | Novartis Pharmaceuticals Corporation | $32 | Food and Beverage | In-kind items and services | COSENTYX Drug, Dermatology | 2025 | |
| 2025-12-04 | ABBVIE INC. | $19 | Food and Beverage | In-kind items and services | SKYRIZI Biological, IMMUNOLOGY | 2025 | |
| 2025-12-04 | Janssen Biotech, Inc. | $4 | Food and Beverage | In-kind items and services | TREMFYA Drug, Immunology | 2025 | |
| 2025-12-02 | Amgen Inc. | $23 | Food and Beverage | In-kind items and services | KRYSTEXXA Biological, Inflammation/Rare Disease | 2025 | |
| 2025-12-01 | SOBI, INC | $30 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-11-26 | ABBVIE INC. | $34 | Food and Beverage | In-kind items and services | SKYRIZI Biological, IMMUNOLOGY | 2025 | |
| 2025-11-25 | ABBVIE INC. | $28 | Food and Beverage | In-kind items and services | RINVOQ Biological, IMMUNOLOGY | 2025 | |
| 2025-11-25 | Amgen Inc. | $7 | Food and Beverage | In-kind items and services | EVENITY Biological, Bone Health | 2025 | |
| 2025-11-24 | Amgen Inc. | $2,700 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | KRYSTEXXA Biological, Inflammation/Rare Disease | 2025 | |
| 2025-11-24 | Novartis Pharmaceuticals Corporation | $22 | Food and Beverage | In-kind items and services | COSENTYX Drug, Dermatology | 2025 | |
| 2025-11-24 | Amgen Inc. | $10 | Travel and Lodging | Cash or cash equivalent | KRYSTEXXA Biological, Inflammation/Rare Disease | 2025 | |
| 2025-11-24 | Amgen Inc. | $4 | Travel and Lodging | Cash or cash equivalent | KRYSTEXXA Biological, Inflammation/Rare Disease | 2025 | |
| 2025-11-20 | Janssen Biotech, Inc. | $24 | Food and Beverage | In-kind items and services | TREMFYA Drug, Immunology | 2025 | |
| 2025-11-20 | Janssen Biotech, Inc. | $1 | Food and Beverage | In-kind items and services | TREMFYA Drug, Immunology | 2025 | |
| 2025-11-18 | Amgen Inc. | $33 | Food and Beverage | In-kind items and services | OTEZLA Drug, Inflammation | 2025 | |
| 2025-11-17 | Amgen Inc. | $30 | Food and Beverage | In-kind items and services | KRYSTEXXA Biological, Inflammation/Rare Disease | 2025 | |
| 2025-11-11 | Janssen Biotech, Inc. | $16 | Food and Beverage | In-kind items and services | TREMFYA Drug, Immunology | 2025 | |
| 2025-11-11 | Janssen Biotech, Inc. | $6 | Food and Beverage | In-kind items and services | TREMFYA Drug, Immunology | 2025 | |
| 2025-11-11 | Janssen Biotech, Inc. | $4 | Food and Beverage | In-kind items and services | TREMFYA Drug, Immunology | 2025 | |
| 2025-11-11 | Janssen Biotech, Inc. | $1 | Food and Beverage | In-kind items and services | TREMFYA Drug, Immunology | 2025 | |
| 2025-11-10 | Novartis Pharmaceuticals Corporation | $26 | Food and Beverage | In-kind items and services | COSENTYX Drug, Dermatology | 2025 | |
| 2025-11-10 | Amgen Inc. | $7 | Food and Beverage | In-kind items and services | ENBREL Biological, Inflammation | 2025 | |
| 2025-11-07 | Janssen Biotech, Inc. | $11 | Food and Beverage | In-kind items and services | TREMFYA Drug, Immunology | 2025 | |
| 2025-11-07 | Janssen Biotech, Inc. | $8 | Food and Beverage | In-kind items and services | TREMFYA Drug, Immunology | 2025 | |
| 2025-11-05 | Boehringer Ingelheim Pharmaceuticals, Inc. | $5,670 | Consulting Fee | Cash or cash equivalent | 2025 | ||
| 2025-11-05 | Boehringer Ingelheim Pharmaceuticals, Inc. | $140 | Travel and Lodging | In-kind items and services | 2025 | ||
| 2025-11-05 | Boehringer Ingelheim Pharmaceuticals, Inc. | $35 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-11-05 | Amgen Inc. | $26 | Food and Beverage | In-kind items and services | KRYSTEXXA Biological, Inflammation/Rare Disease | 2025 | |
| 2025-11-04 | Novartis Pharmaceuticals Corporation | $11 | Food and Beverage | In-kind items and services | COSENTYX Drug, Dermatology | 2025 | |
| 2025-11-03 | Amgen Inc. | $29 | Food and Beverage | In-kind items and services | UPLIZNA Biological, Inflammation/Rare Disease | 2025 | |
| 2025-10-31 | UCB, Inc. | $22 | Food and Beverage | In-kind items and services | Bimzelx Biological, Immunology | 2025 | |
| 2025-10-31 | Amgen Inc. | $13 | Food and Beverage | In-kind items and services | KRYSTEXXA Biological, Inflammation/Rare Disease | 2025 | |
| 2025-10-30 | E.R. Squibb & Sons, L.L.C. | $2,400 | Consulting Fee | Cash or cash equivalent | 2025 | ||
| 2025-10-30 | ABBVIE INC. | $34 | Food and Beverage | In-kind items and services | SKYRIZI Biological, IMMUNOLOGY | 2025 | |
| 2025-10-30 | Amgen Inc. | $8 | Food and Beverage | In-kind items and services | EVENITY Biological, Bone Health | 2025 | |
| 2025-10-29 | Amgen Inc. | $15 | Food and Beverage | In-kind items and services | KRYSTEXXA Biological, Inflammation/Rare Disease | 2025 | |
| 2025-10-28 | Aurinia Pharma U.S., Inc. | $43 | Food and Beverage | In-kind items and services | LUPKYNIS Drug, LUPUS NEPHRITIS | 2025 | |
| 2025-10-28 | Lilly USA, LLC | $20 | Food and Beverage | In-kind items and services | TALTZ Drug, Immunology | 2025 | |
| 2025-10-28 | Amgen Inc. | $8 | Food and Beverage | In-kind items and services | OTEZLA Drug, Inflammation | 2025 | |
| 2025-10-27 | Amgen Inc. | $29 | Travel and Lodging | Cash or cash equivalent | OTEZLA Drug, Inflammation | 2025 | |
| 2025-10-27 | Amgen Inc. | $26 | Food and Beverage | In-kind items and services | OTEZLA Drug, Inflammation | 2025 | |
| 2025-10-27 | ABBVIE INC. | $21 | Food and Beverage | In-kind items and services | RINVOQ Biological, IMMUNOLOGY | 2025 | |
| 2025-10-27 | Amgen Inc. | $4 | Travel and Lodging | Cash or cash equivalent | OTEZLA Drug, Inflammation | 2025 | |
| 2025-10-26 | Amgen Inc. | $139 | Food and Beverage | In-kind items and services | UPLIZNA Biological, Inflammation/Rare Disease | 2025 | |
| 2025-10-26 | Janssen Biotech, Inc. | $100 | Food and Beverage | In-kind items and services | TREMFYA Drug, Immunology | 2025 | |
| 2025-10-26 | Amgen Inc. | $94 | Food and Beverage | In-kind items and services | KRYSTEXXA Biological, Inflammation/Rare Disease | 2025 | |
| 2025-10-26 | Amgen Inc. | $35 | Food and Beverage | In-kind items and services | KRYSTEXXA Biological, Inflammation/Rare Disease | 2025 | |
| 2025-10-26 | Boehringer Ingelheim Pharmaceuticals, Inc. | $10 | Food and Beverage (2 payments) | In-kind items and services | 2025 | ||
| 2025-10-25 | GENZYME CORPORATION | $147 | Food and Beverage | In-kind items and services | KEVZARA Biological, Rheumatology | 2025 | |
| 2025-10-25 | AstraZeneca Pharmaceuticals LP | $37 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-10-24 | Amgen Inc. | $2,700 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | KRYSTEXXA Biological, Inflammation/Rare Disease | 2025 | |
| 2025-10-24 | Amgen Inc. | $450 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | KRYSTEXXA Biological, Inflammation/Rare Disease | 2025 | |
| 2025-10-24 | E.R. Squibb & Sons, L.L.C. | $429 | Travel and Lodging | Cash or cash equivalent | 2025 | ||
| 2025-10-24 | Novartis Pharmaceuticals Corporation | $139 | Food and Beverage | In-kind items and services | COSENTYX Drug, Dermatology | 2025 | |
| 2025-10-24 | E.R. Squibb & Sons, L.L.C. | $64 | Food and Beverage | Cash or cash equivalent | 2025 | ||
| 2025-10-24 | Novartis Pharmaceuticals Corporation | $36 | Food and Beverage | In-kind items and services | COSENTYX Drug, Dermatology | 2025 | |
| 2025-10-24 | E.R. Squibb & Sons, L.L.C. | $18 | Food and Beverage | Cash or cash equivalent | 2025 | ||
| 2025-10-23 | Amgen Inc. | $2,700 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | OTEZLA Drug, Inflammation | 2025 | |
| 2025-10-23 | E.R. Squibb & Sons, L.L.C. | $429 | Travel and Lodging | Cash or cash equivalent | 2025 | ||
| 2025-10-23 | AstraZeneca Pharmaceuticals LP | $25 | Food and Beverage | In-kind items and services | SAPHNELO Biological, Inflammation and Autoimmunity | 2025 | |
| 2025-10-23 | Amgen Inc. | $20 | Travel and Lodging | Cash or cash equivalent | KRYSTEXXA Biological, Inflammation/Rare Disease | 2025 | |
| 2025-10-22 | ABBVIE INC. | $24 | Food and Beverage | In-kind items and services | RINVOQ Biological, IMMUNOLOGY | 2025 | |
| 2025-10-22 | ABBVIE INC. | $3 | Food and Beverage | In-kind items and services | RINVOQ Biological, IMMUNOLOGY | 2025 | |
| 2025-10-21 | Amgen Inc. | $29 | Food and Beverage | In-kind items and services | OTEZLA Drug, Inflammation | 2025 | |
| 2025-10-14 | Amgen Inc. | $2,700 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | OTEZLA Drug, Inflammation | 2025 | |
| 2025-10-14 | Amgen Inc. | $2,700 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | OTEZLA Drug, Inflammation | 2025 | |
| 2025-10-14 | Amgen Inc. | $450 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | OTEZLA Drug, Inflammation | 2025 | |
| 2025-10-14 | Amgen Inc. | $7 | Food and Beverage | In-kind items and services | UPLIZNA Biological, Inflammation/Rare Disease | 2025 | |
| 2025-10-13 | Novartis Pharmaceuticals Corporation | $28 | Food and Beverage | In-kind items and services | COSENTYX Drug, Dermatology | 2025 | |
| 2025-10-09 | ABBVIE INC. | $3,825 | Consulting Fee | Cash or cash equivalent | RINVOQ Biological, IMMUNOLOGY | 2025 | |
| 2025-10-09 | Amgen Inc. | $3,040 | Consulting Fee | Cash or cash equivalent | UPLIZNA Biological, Inflammation/Rare Disease | 2025 | |
| 2025-10-09 | ABBVIE INC. | $1,700 | Consulting Fee | Cash or cash equivalent | RINVOQ Biological, IMMUNOLOGY | 2025 | |
| 2025-10-09 | ABBVIE INC. | $111 | Food and Beverage | In-kind items and services | RINVOQ Biological, IMMUNOLOGY | 2025 | |
| 2025-10-09 | ABBVIE INC. | $53 | Travel and Lodging | In-kind items and services | RINVOQ Biological, IMMUNOLOGY | 2025 | |
| 2025-10-09 | Amgen Inc. | $32 | Food and Beverage | In-kind items and services | OTEZLA Drug, Inflammation | 2025 | |
| 2025-10-08 | ABBVIE INC. | $425 | Consulting Fee | Cash or cash equivalent | 2025 | ||
| 2025-10-07 | ABBVIE INC. | $33 | Food and Beverage | In-kind items and services | SKYRIZI Biological, IMMUNOLOGY | 2025 | |
| 2025-10-06 | Amgen Inc. | $2,250 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | UPLIZNA Biological, Inflammation/Rare Disease | 2025 | |
| 2025-10-06 | Amgen Inc. | $105 | Travel and Lodging | Cash or cash equivalent | OTEZLA Drug, Inflammation | 2025 | |
| 2025-10-06 | Amgen Inc. | $22 | Food and Beverage | Cash or cash equivalent | OTEZLA Drug, Inflammation | 2025 | |
| 2025-10-06 | Novartis Pharmaceuticals Corporation | $16 | Food and Beverage | In-kind items and services | COSENTYX Drug, Dermatology | 2025 | |
| 2025-09-30 | Amgen Inc. | $82 | Food and Beverage | In-kind items and services | OTEZLA Drug, Inflammation | 2025 | |
| 2025-09-29 | Janssen Biotech, Inc. | $34 | Travel and Lodging | Cash or cash equivalent | TREMFYA Drug, Immunology | 2025 | |
| 2025-09-29 | Amgen Inc. | $31 | Food and Beverage | In-kind items and services | OTEZLA Drug, Inflammation | 2025 | |
| 2025-09-29 | Janssen Biotech, Inc. | $25 | Travel and Lodging | Cash or cash equivalent | TREMFYA Drug, Immunology | 2025 | |
| 2025-09-27 | Boehringer Ingelheim Pharmaceuticals, Inc. | $122 | Travel and Lodging | In-kind items and services | 2025 | ||
| 2025-09-25 | Amgen Inc. | $2,700 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | KRYSTEXXA Biological, Inflammation/Rare Disease | 2025 | |
| 2025-09-25 | Amgen Inc. | $450 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | KRYSTEXXA Biological, Inflammation/Rare Disease | 2025 | |
| 2025-09-25 | Amgen Inc. | $130 | Food and Beverage | In-kind items and services | KRYSTEXXA Biological, Inflammation/Rare Disease | 2025 | |
| 2025-09-25 | ABBVIE INC. | $34 | Food and Beverage | In-kind items and services | SKYRIZI Biological, IMMUNOLOGY | 2025 | |
| 2025-09-23 | ABBVIE INC. | $17 | Food and Beverage | In-kind items and services | RINVOQ Biological, IMMUNOLOGY | 2025 | |
| 2025-09-22 | ABBVIE INC. | $30 | Food and Beverage | In-kind items and services | RINVOQ Biological, IMMUNOLOGY | 2025 | |
| 2025-09-22 | Amgen Inc. | $4 | Food and Beverage | In-kind items and services | OTEZLA Drug, Inflammation | 2025 | |
| 2025-09-22 | Amgen Inc. | $2 | Food and Beverage | In-kind items and services | UPLIZNA Biological, Inflammation/Rare Disease | 2025 | |
| 2025-09-20 | Janssen Biotech, Inc. | $2,280 | Consulting Fee | Cash or cash equivalent | TREMFYA Drug, Immunology | 2025 | |
| 2025-09-20 | Boehringer Ingelheim Pharmaceuticals, Inc. | $148 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-09-20 | Novartis Pharmaceuticals Corporation | $96 | Food and Beverage | In-kind items and services | COSENTYX Drug, Dermatology | 2025 | |
| 2025-09-20 | Lilly USA, LLC | $35 | Food and Beverage | In-kind items and services | TALTZ Drug, Immunology | 2025 | |
| 2025-09-20 | E.R. Squibb & Sons, L.L.C. | $17 | Food and Beverage | Cash or cash equivalent | Sotyktu Drug, Immunology | 2025 | |
| 2025-09-19 | Janssen Biotech, Inc. | $149 | Food and Beverage | In-kind items and services | TREMFYA Drug, Immunology | 2025 | |
| 2025-09-19 | ABBVIE INC. | $82 | Food and Beverage | In-kind items and services | RINVOQ Biological, IMMUNOLOGY | 2025 | |
| 2025-09-19 | AstraZeneca Pharmaceuticals LP | $81 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-09-19 | UCB, Inc. | $66 | Food and Beverage | In-kind items and services | Bimzelx Biological, Immunology | 2025 | |
| 2025-09-19 | Amgen Inc. | $50 | Food and Beverage | In-kind items and services | KRYSTEXXA Biological, Inflammation/Rare Disease | 2025 | |
| 2025-09-18 | Amgen Inc. | $85 | Food and Beverage | In-kind items and services | UPLIZNA Biological, Inflammation/Rare Disease | 2025 | |
| 2025-09-18 | ABBVIE INC. | $54 | Food and Beverage | In-kind items and services | RINVOQ Biological, IMMUNOLOGY | 2025 | |
| 2025-09-17 | Boehringer Ingelheim Pharmaceuticals, Inc. | $178 | Travel and Lodging | In-kind items and services | 2025 | ||
| 2025-09-17 | Amgen Inc. | $147 | Food and Beverage | In-kind items and services | UPLIZNA Biological, Inflammation/Rare Disease | 2025 | |
| 2025-09-17 | Boehringer Ingelheim Pharmaceuticals, Inc. | $117 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-09-17 | Janssen Biotech, Inc. | $59 | Food and Beverage | In-kind items and services | TREMFYA Drug, Immunology | 2025 | |
| 2025-09-17 | Boehringer Ingelheim Pharmaceuticals, Inc. | $51 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-09-17 | Boehringer Ingelheim Pharmaceuticals, Inc. | $43 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-09-17 | Boehringer Ingelheim Pharmaceuticals, Inc. | $35 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-09-17 | Janssen Biotech, Inc. | $20 | Food and Beverage | In-kind items and services | TREMFYA Drug, Immunology | 2025 | |
| 2025-09-16 | UCB, Inc. | $23 | Food and Beverage | In-kind items and services | Bimzelx Biological, Immunology | 2025 | |
| 2025-09-15 | Novartis Pharmaceuticals Corporation | $29 | Food and Beverage | In-kind items and services | COSENTYX Drug, Dermatology | 2025 | |
| 2025-09-12 | Amgen Inc. | $13 | Food and Beverage | In-kind items and services | UPLIZNA Biological, Inflammation/Rare Disease | 2025 | |
| 2025-09-11 | SOBI, INC | $2,140 | Consulting Fee | Cash or cash equivalent | Gamifant Drug, Hematology | 2025 | |
| 2025-09-11 | Radius Health, Inc. | $18 | Food and Beverage | In-kind items and services | Tymlos Drug, Endocrinology | 2025 | |
| 2025-09-10 | Boehringer Ingelheim Pharmaceuticals, Inc. | $350 | Travel and Lodging | In-kind items and services | 2025 | ||
| 2025-09-10 | PFIZER INC. | $26 | Food and Beverage | In-kind items and services | XELJANZ Drug, GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | 2025 | |
| 2025-09-09 | Lilly USA, LLC | $22 | Food and Beverage | In-kind items and services | TALTZ Drug, Immunology | 2025 | |
| 2025-09-08 | Amgen Inc. | $363 | Travel and Lodging | In-kind items and services | KRYSTEXXA Biological, Inflammation/Rare Disease | 2025 | |
| 2025-09-08 | Amgen Inc. | $29 | Food and Beverage | In-kind items and services | KRYSTEXXA Biological, Inflammation/Rare Disease | 2025 | |
| 2025-09-08 | Amgen Inc. | $10 | Food and Beverage | In-kind items and services | ENBREL Biological, Inflammation | 2025 | |
| 2025-09-05 | ABBVIE INC. | $853 | Travel and Lodging | In-kind items and services | RINVOQ Biological, IMMUNOLOGY | 2025 | |
| 2025-09-05 | ABBVIE INC. | $215 | Travel and Lodging | In-kind items and services | RINVOQ Biological, IMMUNOLOGY | 2025 | |
| 2025-09-05 | ABBVIE INC. | $40 | Food and Beverage | In-kind items and services | RINVOQ Biological, IMMUNOLOGY | 2025 | |
| 2025-09-05 | ABBVIE INC. | $40 | Food and Beverage | In-kind items and services | RINVOQ Biological, IMMUNOLOGY | 2025 | |
| 2025-09-05 | ABBVIE INC. | $12 | Food and Beverage | In-kind items and services | RINVOQ Biological, IMMUNOLOGY | 2025 | |
| 2025-09-05 | ABBVIE INC. | $12 | Food and Beverage | In-kind items and services | RINVOQ Biological, IMMUNOLOGY | 2025 | |
| 2025-09-04 | ABBVIE INC. | $26 | Food and Beverage | In-kind items and services | SKYRIZI Biological, IMMUNOLOGY | 2025 | |
| 2025-09-03 | Amgen Inc. | $31 | Food and Beverage | In-kind items and services | KRYSTEXXA Biological, Inflammation/Rare Disease | 2025 | |
| 2025-08-28 | Lilly USA, LLC | $29 | Food and Beverage | In-kind items and services | TALTZ Drug, Immunology | 2025 | |
| 2025-08-28 | ABBVIE INC. | $8 | Food and Beverage | In-kind items and services | RINVOQ Biological, IMMUNOLOGY | 2025 | |
| 2025-08-27 | Janssen Biotech, Inc. | $37 | Food and Beverage | In-kind items and services | TREMFYA Drug, Immunology | 2025 | |
| 2025-08-26 | Amgen Inc. | $2,700 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | OTEZLA Drug, Inflammation | 2025 | |
| 2025-08-26 | Novartis Pharmaceuticals Corporation | $21 | Food and Beverage | In-kind items and services | COSENTYX Drug, Dermatology | 2025 | |
| 2025-08-26 | Amgen Inc. | $2 | Travel and Lodging | Cash or cash equivalent | OTEZLA Drug, Inflammation | 2025 | |
| 2025-08-25 | GlaxoSmithKline, LLC. | $24 | Food and Beverage | In-kind items and services | BENLYSTA Biological, IMMUNOLOGY | 2025 | |
| 2025-08-23 | SOBI, INC | $87 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-08-23 | Amgen Inc. | $8 | Food and Beverage | In-kind items and services | TAVNEOS Drug, Inflammation | 2025 | |
| 2025-08-22 | Amgen Inc. | $28 | Food and Beverage | In-kind items and services | OTEZLA Drug, Inflammation | 2025 | |
| 2025-08-21 | Amgen Inc. | $21 | Food and Beverage | In-kind items and services | KRYSTEXXA Biological, Inflammation/Rare Disease | 2025 | |
| 2025-08-20 | Amgen Inc. | $34 | Food and Beverage | In-kind items and services | ENBREL Biological, Inflammation | 2025 | |
| 2025-08-20 | Amgen Inc. | $9 | Food and Beverage | In-kind items and services | TAVNEOS Drug, Inflammation | 2025 | |
| 2025-08-19 | Amgen Inc. | $2,700 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | UPLIZNA Biological, Inflammation/Rare Disease | 2025 | |
| 2025-08-18 | Amgen Inc. | $6 | Travel and Lodging | Cash or cash equivalent | UPLIZNA Biological, Inflammation/Rare Disease | 2025 | |
| 2025-08-14 | ABBVIE INC. | $31 | Food and Beverage | In-kind items and services | SKYRIZI Biological, IMMUNOLOGY | 2025 | |
| 2025-08-13 | Amgen Inc. | $18 | Food and Beverage | In-kind items and services | EVENITY Biological, Bone Health | 2025 | |
| 2025-08-12 | Lilly USA, LLC | $31 | Food and Beverage | In-kind items and services | TALTZ Drug, Immunology | 2025 | |
| 2025-08-12 | Amgen Inc. | $5 | Food and Beverage | In-kind items and services | OTEZLA Drug, Inflammation | 2025 | |
| 2025-08-11 | Amgen Inc. | $99 | Food and Beverage | In-kind items and services | UPLIZNA Biological, Inflammation/Rare Disease | 2025 | |
| 2025-08-11 | Boehringer Ingelheim Pharmaceuticals, Inc. | $12 | Food and Beverage | In-kind items and services | OFEV Drug, RESPIRATORY | 2025 | |
| 2025-08-06 | ABBVIE INC. | $2,125 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | SKYRIZI Biological, IMMUNOLOGY | 2025 | |
| 2025-08-06 | Radius Health, Inc. | $32 | Food and Beverage | In-kind items and services | Tymlos Drug, Endocrinology | 2025 | |
| 2025-08-06 | ABBVIE INC. | $6 | Food and Beverage | In-kind items and services | SKYRIZI Biological, IMMUNOLOGY | 2025 | |
| 2025-08-05 | UCB, Inc. | $2,500 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Bimzelx Biological, Immunology | 2025 | |
| 2025-08-05 | UCB, Inc. | $15 | Travel and Lodging | Cash or cash equivalent | Bimzelx Biological, Immunology | 2025 | |
| 2025-07-30 | Novartis Pharmaceuticals Corporation | $17 | Food and Beverage | In-kind items and services | COSENTYX Drug, Dermatology | 2025 | |
| 2025-07-29 | Amgen Inc. | $23 | Food and Beverage | In-kind items and services | OTEZLA Drug, Inflammation | 2025 | |
| 2025-07-28 | ABBVIE INC. | $31 | Food and Beverage | In-kind items and services | RINVOQ Biological, IMMUNOLOGY | 2025 | |
| 2025-07-24 | ABBVIE INC. | $2,125 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | SKYRIZI Biological, IMMUNOLOGY | 2025 | |
| 2025-07-24 | UCB, Inc. | $122 | Food and Beverage | In-kind items and services | Bimzelx Biological, Immunology | 2025 | |
| 2025-07-23 | Amgen Inc. | $30 | Food and Beverage | In-kind items and services | TAVNEOS Drug, Inflammation | 2025 | |
| 2025-07-22 | ABBVIE INC. | $31 | Food and Beverage | In-kind items and services | SKYRIZI Biological, IMMUNOLOGY | 2025 | |
| 2025-07-21 | GlaxoSmithKline, LLC. | $24 | Food and Beverage | In-kind items and services | BENLYSTA Biological, IMMUNOLOGY | 2025 | |
| 2025-07-17 | UCB, Inc. | $40 | Food and Beverage | In-kind items and services | Bimzelx Biological, Immunology | 2025 | |
| 2025-07-17 | UCB, Inc. | $0 | Food and Beverage | In-kind items and services | Bimzelx Biological, Immunology | 2025 | |
| 2025-07-16 | ABBVIE INC. | $2,125 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | RINVOQ Biological, IMMUNOLOGY | 2025 | |
| 2025-07-16 | Boehringer Ingelheim Pharmaceuticals, Inc. | $28 | Food and Beverage | In-kind items and services | OFEV Drug, RESPIRATORY | 2025 | |
| 2025-07-15 | Lilly USA, LLC | $27 | Food and Beverage | In-kind items and services | TALTZ Drug, Immunology | 2025 | |
| 2025-07-15 | E.R. Squibb & Sons, L.L.C. | $7 | Food and Beverage | Cash or cash equivalent | ORENCIA Biological, Immunology | 2025 | |
| 2025-07-15 | UCB, Inc. | $6 | Travel and Lodging | In-kind items and services | Bimzelx Biological, Immunology | 2025 | |
| 2025-07-14 | ABBVIE INC. | $96 | Food and Beverage | In-kind items and services | SKYRIZI Biological, IMMUNOLOGY | 2025 | |
| 2025-07-14 | Mallinckrodt Hospital Products Inc. | $29 | Food and Beverage | In-kind items and services | ACTHAR Biological, IMMUNOLOGY | 2025 | |
| 2025-07-07 | ABBVIE INC. | $75 | Travel and Lodging | In-kind items and services | RINVOQ Biological, IMMUNOLOGY | 2025 | |
| 2025-07-07 | ABBVIE INC. | $68 | Food and Beverage | In-kind items and services | RINVOQ Biological, IMMUNOLOGY | 2025 | |
| 2025-07-07 | ABBVIE INC. | $7 | Travel and Lodging | In-kind items and services | RINVOQ Biological, IMMUNOLOGY | 2025 | |
| 2025-06-30 | ABBVIE INC. | $582 | Travel and Lodging | In-kind items and services | SKYRIZI Biological, IMMUNOLOGY | 2025 | |
| 2025-06-28 | Novartis Pharmaceuticals Corporation | $6,225 | Consulting Fee | Cash or cash equivalent | COSENTYX Drug, Dermatology | 2025 | |
| 2025-06-28 | Novartis Pharmaceuticals Corporation | $169 | Travel and Lodging | In-kind items and services | COSENTYX Drug, Dermatology | 2025 | |
| 2025-06-28 | Novartis Pharmaceuticals Corporation | $169 | Food and Beverage | In-kind items and services | COSENTYX Drug, Dermatology | 2025 | |
| 2025-06-28 | Novartis Pharmaceuticals Corporation | $73 | Food and Beverage | In-kind items and services | COSENTYX Drug, Dermatology | 2025 |
The latest 200 records of 2,369.
Research payments naming this person as principal investigator
| Date | Company | Paid to | Amount | Study | Year |
|---|---|---|---|---|---|
| 2025-12-04 | ABBVIE INC. | SOLACE CLINICAL RESEARCH LLC | $603 | Program to Assess Adverse Events and Change in Disease Activity of Oral Upadacitinib in Adult Participants With Moderate | 2025 |
| 2025-12-04 | ABBVIE INC. | SOLACE CLINICAL RESEARCH LLC | $272 | Program to Assess Adverse Events and Change in Disease Activity of Oral Upadacitinib in Adult Participants With Moderate | 2025 |
| 2025-10-15 | ABBVIE INC. | SOLACE CLINICAL RESEARCH LLC | $4,410 | Program to Assess Adverse Events and Change in Disease Activity of Oral Upadacitinib in Adult Participants With Moderate | 2025 |
| 2025-09-05 | Janssen Research & Development, LLC | SOLACE CLINICAL RESEARCH LLC | $18,470 | ?A Randomized, Placebo-controlled, Double-blind, Multicenter Phase 3 Protocol to Assess the Efficacy and Safety of Nipoc | 2025 |
| 2025-09-04 | ABBVIE INC. | SOLACE CLINICAL RESEARCH LLC | $10,650 | Program to Assess Adverse Events and Change in Disease Activity of Oral Upadacitinib in Adult Participants With Moderate | 2025 |
| 2023-03-22 | Eli Lilly and Company | ROBIN K DORE MD INC | $656 | A RANDOMIZED CONTROLLED PRAGMATIC PHASE 3B/4 STUDY OF BARICITINIB IN PATIENTS WITH RHEUMATOID ARTHRITIS | 2023 |
| 2022-02-15 | Eli Lilly and Company | ROBIN K DORE MD INC | $938 | A RANDOMIZED, ACTIVE-CONTROLLED, PARALLEL-GROUP, PHASE 3B/4 STUDY OF BARICITINIB IN PATIENTS WITH RHEUMATOID ARTHRITIS | 2022 |
| 2022-01-26 | Amgen Inc. | ROBIN K DORE MD INC | $16 | Ph4 Otezla in oligoarticular PsA (FOREMOST)/KEG | 2022 |
| 2022-01-01 | Eli Lilly and Company | ROBIN K DORE MD INC | $6,936 | A RANDOMIZED, CONTROLLED PRAGMATIC PHASE 3B/4 STUDY OF BARICITINIB IN PATIENTS WITH RHEUMATOID ARTHRITIS | 2022 |
| 2021-06-24 | Amgen Inc. | ROBIN K DORE MD INC | $305 | PSA-013/20200058 (KEG) (FOREMOST) | 2021 |
| 2021-04-01 | Eli Lilly and Company | ROBIN K DORE MD INC | $5,920 | A RANDOMIZED, CONTROLLED PRAGMATIC PHASE 3B/4 STUDY OF BARICITINIB IN PATIENTS WITH RHEUMATOID ARTHRITIS | 2021 |
| 2020-03-09 | Eli Lilly and Company | ROBIN K DORE MD INC | $198 | A RANDOMIZED, ACTIVE-CONTROLLED, PARALLEL-GROUP, PHASE 3B/4 STUDY OF BARICITINIB IN PATIENTS WITH RHEUMATOID ARTHRITIS | 2020 |
| 2020-03-03 | Eli Lilly and Company | ROBIN K DORE MD INC | $5,720 | A RANDOMIZED, ACTIVE-CONTROLLED, PARALLEL-GROUP, PHASE 3B/4 STUDY OF BARICITINIB IN PATIENTS WITH RHEUMATOID ARTHRITIS | 2020 |
| 2019-06-07 | Eli Lilly and Company | ROBIN K DORE MD INC | $1,838 | A RANDOMIZED, ACTIVE-CONTROLLED, PARALLEL-GROUP, PHASE 3B/4 STUDY OF BARICITINIB IN PATIENTS WITH RHEUMATOID ARTHRITIS | 2019 |
| 2019-01-01 | Amgen Inc. | University Of California Irvine Health | $56 | Enbrel RA Remission Study | 2019 |
CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.
The area Census
County outline, the place (blue), the tract (orange) and the ZIP center (dot).
In Tustin, CA, county Orange County, CA, state California; placed by its city name.
| Measure | Place (city or town) Tustin, CA | County Orange County, CA | State California |
|---|---|---|---|
| Population B01003 | 78,981 | 3,165,820 | 39,287,377 |
| Population, 2020 census P1 | 80,276 | 3,186,989 | 39,538,223 |
| Median age B01002 | 37.5 | 39.4 | 37.9 |
| Under 18 B01001 | 22.5% | 21.0% | 22.0% |
| 65 and over B01001 | 13.1% | 16.3% | 15.7% |
| Households B11001 | 27,551 | 1,082,960 | 13,548,091 |
| Foreign born B05002 | 34.0% | 30.4% | 27.0% |
| Median household income B19013 | $112,503 | $116,289 | $99,122 |
| Median family income B19113 | $128,426 | $132,827 | $113,346 |
| Per capita income B19301 | $54,989 | $54,557 | $49,513 |
| Poverty rate B17001 | 9.9% | 9.5% | 12.0% |
| Unemployment rate B23025 | 5.4% | 5.4% | 6.6% |
| Civilian labor force B23025 | 44,103 | 1,692,091 | 20,068,466 |
| Mean commute (minutes) B08013 | 22.8 | 26.7 | 28.7 |
| Bachelor's degree or higher B15003 | 47.4% | 44.1% | 37.1% |
| Housing units B25001 | 28,482 | 1,146,169 | 14,644,735 |
| Owner-occupied B25003 | 48.8% | 56.4% | 55.9% |
| Renters B25003 | 51.2% | 43.6% | 44.1% |
| Median home value B25077 | $950,400 | $962,600 | $734,700 |
| Median gross rent B25064 | $2,449 | $2,434 | $2,036 |
| White, not Hispanic B03002 | 25.5% | 36.9% | 33.8% |
| Black B03002 | 2.5% | 1.5% | 5.2% |
| Hispanic or Latino B03002 | 41.2% | 34.2% | 40.2% |
| Asian B03002 | 26.2% | 22.2% | 15.3% |
| American Indian and Alaska Native B03002 | 0.2% | 0.1% | 0.3% |
Economy now FRED unemployment 5.1% in Sep 2026 (5.5% a year earlier); per capita personal income $90,957 in 2025, up 30% in five years (+4.3% after inflation); the state; Source: FRED, Federal Reserve Bank of St. Louis.
Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Tustin, CA.
Comments